Literature DB >> 18296557

Role of 12/15-lipoxygenase in the expression of MCP-1 in mouse macrophages.

Yeshao Wen1, Jiali Gu, George E Vandenhoff, Xiaoping Liu, Jerry L Nadler.   

Abstract

Monocyte chemoattractant protein (MCP)-1 plays a key role in atherosclerosis and inflammation associated with visceral adiposity by inducing mononuclear cell migration. Evidence shows that mouse peritoneal macrophages (MPM) express a 12-lipoxygenase (12/15-LO) that has been clearly linked to accelerated atherosclerosis in mouse models and increased monocyte endothelial interactions in both rodent and human cells. However, the role of 12/15-LO products in regulating MCP-1 expression in macrophages has not been clarified. In this study, we tested the role of 12/15-LO products using MPM and the mouse macrophage cell line, J774A.1 cells. We found that 12(S)-hydroxyeicosatetraenoic acid [12(S)-HETE] increased MCP-1 mRNA and protein expression in J774A.1 cells and MPM. In contrast, 12(R)-HETE, a lipid not derived from 12/15-LO, did not affect MCP-1 expression. 15(S)-HETE also increased MCP-1 mRNA expression, but the effect was less compared with 12(S)-HETE. MCP-1 mRNA expression was upregulated in a macrophage cell line stably overexpressing 12/15-LO (Plox-86 cells) and in MPM isolated from a 12/15-LO transgenic mouse. In addition, the expression of MCP-1 was downregulated in MPM isolated from 12/15-LO knockout mice. 12(S)-HETE-induced MCP-1 mRNA expression was attenuated by specific inhibitors of protein kinase C (PKC) and p38 mitogen-activated protein kinase (p38). 12(S)-HETE also directly activated NADPH oxidase activity. Two NADPH oxidase inhibitors, apocynin and diphenyleneiodonium chloride, blocked 12(S)-HETE-induced MCP-1 mRNA. Apocynin attenuated 12(S)-HETE-induced MCP-1 protein secretion. These data show that 12(S)-HETE increases MCP-1 expression by inducing PKC, p38, and NADPH oxidase activity. These results suggest a potentially important mechanism linking 12/15-LO activation to MCP-1 expression that induces inflammatory cell infiltration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18296557     DOI: 10.1152/ajpheart.00260.2007

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  33 in total

1.  ALOX12 in human toxoplasmosis.

Authors:  William H Witola; Susan Ruosu Liu; Alexandre Montpetit; Ruth Welti; Magali Hypolite; Mary Roth; Ying Zhou; Ernest Mui; Marie-France Cesbron-Delauw; Gilbert J Fournie; Pierre Cavailles; Cordelia Bisanz; Kenneth Boyer; Shawn Withers; A Gwendolyn Noble; Charles N Swisher; Peter T Heydemann; Peter Rabiah; Stephen P Muench; Rima McLeod
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

2.  Borrelia burgdorferi infection induces lipid mediator production during Lyme arthritis.

Authors:  Charles R Brown; Edward A Dennis
Journal:  Biochimie       Date:  2017-06-16       Impact factor: 4.079

Review 3.  Eicosanoids, β-cell function, and diabetes.

Authors:  Pengcheng Luo; Mong-Heng Wang
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-07-03       Impact factor: 3.072

4.  Differential expression and localization of 12/15 lipoxygenases in adipose tissue in human obese subjects.

Authors:  Anca D Dobrian; David C Lieb; Qian Ma; John W Lindsay; Banumathi K Cole; Kaiwen Ma; Swarup K Chakrabarti; Norine S Kuhn; Stephen D Wohlgemuth; Mark Fontana; Jerry L Nadler
Journal:  Biochem Biophys Res Commun       Date:  2010-11-19       Impact factor: 3.575

5.  Regulation of the development of asthmatic inflammation by in situ CD4(+)Foxp3 (+) T cells in a mouse model of late allergic asthma.

Authors:  Tomomi Nakashima; Toshiharu Hayashi; Takuya Mizuno
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

6.  12-Lipoxygenase-knockout mice are resistant to inflammatory effects of obesity induced by Western diet.

Authors:  Craig S Nunemaker; Meng Chen; Hong Pei; Sarah D Kimble; Susanna R Keller; Jeffrey D Carter; Zandong Yang; Kellie M Smith; Runpei Wu; Melissa H Bevard; James C Garmey; Jerry L Nadler
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-09-09       Impact factor: 4.310

7.  Effects of cholesterol-tagged small interfering RNAs targeting 12/15-lipoxygenase on parameters of diabetic nephropathy in a mouse model of type 1 diabetes.

Authors:  Hang Yuan; Linda Lanting; Zhong-Gao Xu; Shu-Lian Li; Piotr Swiderski; Sumanth Putta; Mahesh Jonnalagadda; Mitsuo Kato; Rama Natarajan
Journal:  Am J Physiol Renal Physiol       Date:  2008-06-18

8.  12-Lipoxygenase Products Reduce Insulin Secretion and {beta}-Cell Viability in Human Islets.

Authors:  K Ma; C S Nunemaker; R Wu; S K Chakrabarti; D A Taylor-Fishwick; J L Nadler
Journal:  J Clin Endocrinol Metab       Date:  2010-01-20       Impact factor: 5.958

9.  Cardiac 12/15 lipoxygenase-induced inflammation is involved in heart failure.

Authors:  Yosuke Kayama; Tohru Minamino; Haruhiro Toko; Masaya Sakamoto; Ippei Shimizu; Hidehisa Takahashi; Sho Okada; Kaoru Tateno; Junji Moriya; Masataka Yokoyama; Aika Nojima; Michihiro Yoshimura; Kensuke Egashira; Hiroyuki Aburatani; Issei Komuro
Journal:  J Exp Med       Date:  2009-06-22       Impact factor: 14.307

10.  12/15-lipoxygenase is required for the early onset of high fat diet-induced adipose tissue inflammation and insulin resistance in mice.

Authors:  Dorothy D Sears; Philip D Miles; Justin Chapman; Jachelle M Ofrecio; Felicidad Almazan; Divya Thapar; Yury I Miller
Journal:  PLoS One       Date:  2009-09-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.